EFFICACY AND SAFETY OF SOFOSBUVIR/ VELPATASVIR WITH OR WITHOUT RIBAVIRIN IN HCV- INFECTED CHINESE PATIENTS: A PROSPECTIVE COHORT STUDY

被引：0

作者：

Wang, Jiayi ^{[1
]}

Du, Lingyao ^{[1
]}

Zhou, Chen ^{[1
]}

Zeng, Yilan ^{[2
]}

Chen, Enqiang ^{[1
]}

Zhang, Dong-Mei ^{[1
]}

Cheng, Xing ^{[1
]}

Song, Xiaona ^{[1
]}

Han, Ning ^{[1
]}

Liu, Miao ^{[1
]}

Chen, Han ^{[1
]}

Tang, Hong ^{[1
]}

机构：

[1] Sichuan Univ, West China Hosp, Div Infect Dis, Ctr Infect Dis,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China

[2] Publ Hlth Clin Ctr Chengdu, Chengdu 610041, Sichuan, Peoples R China

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1868A

引用

页码：S718 / S719

页数：2

共 50 条

[1] Safety and efficacy of Sofosbuvir/Velpatasvir with and without Ribavirin in genotype 3HCV-infected patients with cirrhosis
Ferret, M. B.
Pineda, J.
Panero, J. L. C.
Rodriguez, M.
Morillas, R. M.
Pascasio, J. M.
Rivero, A.
Mcnabb, B.
Zhang, G.
Camus, G.
Stamm, L.
Brainard, D.
Subramanian, M.
Carrion, J. A.
Andrade, R. J.
Amado, L. E. M.
Turnes, J.
Lens, S.
Casado, M.
Esteban, R.
JOURNAL OF HEPATOLOGY, 2018, 68 : S20 - S21
[2] Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1-6: results of the HCV-TARGET Study
Khalili, M.
Welzel, T. M.
Lim, J. K.
Lutchman, G. A.
Nelson, D. R.
Borg, B.
Lok, A. S.
Ramani, A.
Reau, N.
Vainorius, M.
Fried, M. W.
Landis, C. S.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S716 - S717
[3] Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
Tetsuo Takehara
Naoya Sakamoto
Shuhei Nishiguchi
Fusao Ikeda
Tomohide Tatsumi
Yoshiyuki Ueno
Hiroshi Yatsuhashi
Yasuhiro Takikawa
Tatsuo Kanda
Minoru Sakamoto
Akihiro Tamori
Eiji Mita
Kazuaki Chayama
Gulan Zhang
Shampa De-Oertel
Hadas Dvory-Sobol
Takuma Matsuda
Luisa M. Stamm
Diana M. Brainard
Yasuhito Tanaka
Masayuki Kurosaki
Journal of Gastroenterology, 2019, 54 : 87 - 95
[4] A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)
Wilson, Eleanor
Covert, Emily
Hoffmann, Jennifer
Comstock, Emily
Emmanuel, Benjamin
Tang, Lydia
Husson, Jennifer
Chua, Joel
Price, Angie
Mathur, Poonam
Rosenthal, Elana
Kattakuzhy, Sarah
Masur, Henry
Kottilil, Shyam
JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 498 - 504
[5] Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
Takehara, Tetsuo
Sakamoto, Naoya
Nishiguchi, Shuhei
Ikeda, Fusao
Tatsumi, Tomohide
Ueno, Yoshiyuki
Yatsuhashi, Hiroshi
Takikawa, Yasuhiro
Kanda, Tatsuo
Sakamoto, Minoru
Tamori, Akihiro
Mita, Eiji
Chayama, Kazuaki
Zhang, Gulan
De-Oertel, Shampa
Dvory-Sobol, Hadas
Matsuda, Takuma
Stamm, Luisa M.
Brainard, Diana M.
Tanaka, Yasuhito
Kurosaki, Masayuki
JOURNAL OF GASTROENTEROLOGY, 2019, 54 (01) : 87 - 95
[6] The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination
Dimitroulopoulos, D.
Karatapanis, S.
Kypreos, D.
Malahias, A.
Tsamakidis, K.
Xinopoulos, D.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 71 - 71
[7] EFFICACY AND SAFETY OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 3 HEPATITIS C VIRUS-INFECTED PATIENTS: A REAL-WORLD STUDY OF CHINA AND SAFETY OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 3 HEPATITIS C VIRUS-INFECTED PATIENTS: A REAL-WORLD STUDY OF CHINA
Yue, Wei
Liu, Li
Xiao, An
Du, Yingrong
Gao, Jianpeng
Liu, Min
Wang, Yilan
Che, Meng
Guo, Jiaxiang
Li, Junyi
Geng, Jiawei
HEPATOLOGY, 2021, 74 : 589A - 589A
[8] Gender Differences in Patients Treated for HCV: Efficacy and Safety of Sofosbuvir/Velpatasvir in Women
Tran, Tram T.
Feld, Jordan J.
Foster, Graham R.
Naik, Sarjita
Eggleton, Edward S.
Zhang, Jie
Natha, Macky
Llewellyn, Joseph
Kreter, Bruce
Brainard, Diana M.
Wyles, David L.
Sulkowski, Mark S.
Rogal, Shari S.
HEPATOLOGY, 2016, 64 : 422A - 422A
[9] Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
Smirne, Carlo
Carbone, Roberto
Colletta, Cosimo
Scivetti, Paolo
Sainaghi, Pier Paolo
Elena, Grossini
Pirisi, Mario
EURASIAN JOURNAL OF MEDICINE, 2022, 54 (02): : 113 - 120
[10] EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN GENOTYPE 3 AND 6 HCV PATIENTS IN EAST CHINA
Wang Donghui
Jiang, Suwen
Liu, Linsong
Fan, Lingyan
Hu, Airong
HEPATOLOGY, 2021, 74 : 589A - 590A

← 1 2 3 4 5 →